CK Life Sciences International (Holdings), Inc. (0775.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
| Market Cap | 7.88B |
| Enterprise Value | 13.9B |
| P/E Ratio | -30.41 |
| PEG Ratio | 0.24 |
| Price/Sales Ratio | 1.05 |
| Price/Book Ratio | 1.52 |
| Enterprise/Revenue | 2.16 |
| Enterprise/EBITDA | -258.79 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.03 |
| Operating Margin | 0.02 |
| Return On Assets | -0.02 |
| Return On Equity | -0.05 |
| Revenue | 5.41B |
| Revenue/Share | 0.56 |
| Gross Profit | 785.39M |
| EBITDA | -49.42M |
| Net Income | -188.45M |
| Diluted EPS | -0.02 |
| Total Cash | 603.07M |
| Total Cash/Share | 0.06 |
| Total Debt | 6.62B |
| Total Debt/Equity | 1.75 |
| Current Ratio | 0.87 |
| Book Value Per Share | 0.4 |
| 52-Week Change | -31.4 |
| 52-Week High | 1.08 |
| 52-Week Low | 0.57 |
| Moving Average 50 Days | 0.68 |
| Moving Average 200 Days | 0.79 |
| Average Volume | 2.73M |
| Shares Outstanding | 9.61B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |